Upcoming Issues

Advances in Modern Oncology Research (AMOR) is devoted to invited articles related to the special-issue topic. However, the editorial staff also encourages unsolicited manuscripts on other oncology themes for consideration and publication under the regular issue.

Volume 06

No. 1 | February 2020

Special Issue: Cancer treatment in the aftermath of COVID-19

Submission Deadline : March 15, 2020

Editorial Team

Dr. Bindhu Josep, Kidwai Memorial Institute of Oncology

Dr. Emel Canbay, Faculty of Medicine Department of General Surgery, Biruni University, Istanbul

Dr. Evita B. Henderson-Jackson, University of South Florida School of Medicine

Dr. Frances Josephine Drummond, University College Cork

Dr. Ganapathi Bhat M., Jaslok Hospital & Research Center

Dr. Hussein Fakhry, South Egypt Cancer Institute, Assiut University, Egypt

The COVID-19 pandemic has resulted in unprecedented problems in cancer treatment with both in managing a cohort of immune-compromised high risk cohort of patients as well as providing an organised safe workflow for the oncological health care systems to operate. With the situation constantly changing and an uncertain endpoint for the pandemic, there is an urgent need to rapidly revise the ongoing and established cancer treatment protocols to allow for safe and effective oncological treatment.

There is a need to focus on cancer treatment protocol that is supported by scientific data and can provide at least one or more features like shorter treatment stay, easier or faster treatment delivery, less intensive patient supportive care or health care personal requirements. Limited resources and capacity will require institutions to prioritise the patient who need immediate attention, which treatments can be temporarily suspended or safely delayed because of anticipated biology. This special issue is being brought out to encourage articles that dive into possible solutions, guidelines protocols that may aid the oncology community in facing the global consequences of COVID-19.

Other issues of paramount concern would be the categorisation and treatment of cancer patients with respiratory infections or compromise, resource relocation and restrictive safe measures for healthcare personals, scheduling patient monitoring and follow-up care.

No. 2 | April 2020

Special Issue: Integrating psychosocial care into cancer in different cultural and socioeconomic settings

Submission Deadline : June 1, 2020

Editorial Team

Dr. Carmina Castellano Tejedor, RE-FiT Research Group, Parc Sanitari Pere Virgili – Vall d’Hebron Institute of Research, Barcelona

With the advent of high-throughput technologies, there is a large amount of big data being generated in cancer biology. Advances in understanding the genome and the genetic variations underlying inter-ethnic variability in disease populations have necessitated the use of bioinformatic approaches for a holistic approach to understanding cancer. Biological genetic networks of messenger RNA or noncoding RNA, and protein-protein interaction networks are important to understand network architecture and to discover novel biomarkers for therapeutic intervention. Genomics and proteomics are now being used extensively in a proteogenomics concerted strategy to understand cancer. Circulating markers are being used for diagnostic assessment in cancer. The development of novel machine learning and artificial intelligence-based solutions to big data analysis in cancer is increasing every day. We welcome submissions on all aspects of cancer bioinformatics including the above. As the world is increasingly turning to online resources in the current times, harnessing bioinformatic resources for cancer research will be both necessary and fruitful. We welcome all your cancer bioinformatics submissions.

No. 3 | June 2020

Special Issue: Cancer bioinformatics

Submission Deadline: August 1, 2020

Editorial Team

Dr. Sujit Nair, University of Mumbai

A solid corpus of scientific literature has stressed that oncological patients and their caregivers usually experience significant psychosocial problems throughout their cancer journey. However, many of them still do not receive adequate psychosocial care despite the existence of evidence-based treatments. Consequently, this population is at increased risk of prolonging life without adequately addressing health-related quality of life and psychological well-being among other aspects. There are many challenges to improve the current situation, the major one of which is organizational and linked to economic and health policies. In this sense, many cancer centers still lack a system of psychosocial care integrated with the cancer continuum care service. The integration must occur with the cancer care of the patient at all stages (from screening and diagnosis to palliative care or follow-up consultation) and across all clinical sites of care (inpatient and outpatient cancer services as well as primary care). New theoretical and methodological approaches must be put forward, including the systematic identification of needs at different sites, analyzing current service provision strengths and weaknesses, and testing new approaches that include integrating delivery of care by care managers, appropriate specialist supervision, and the stepping of care based on systematic measurement of outcomes. Studies accurately assessing feasibility, effectiveness and sustainability of this approach at mid-long term are strongly required. Only by doing this, it will be possible to succeed in providing better and more comprehensive care to our oncological patients.

No. 4 | August 2020

AMOR Issue

Submission Deadline : October 1, 2020